BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farhood B, Najafi M, Mortezaee K. Cancer‐associated fibroblasts: Secretions, interactions, and therapy. J Cell Biochem 2019;120:2791-800. [DOI: 10.1002/jcb.27703] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao J, Chen Y. Systematic identification of cancer-associated-fibroblast-derived genes in patients with colorectal cancer based on single-cell sequencing and transcriptomics. Front Immunol 2022;13:988246. [DOI: 10.3389/fimmu.2022.988246] [Reference Citation Analysis]
2 Wu J, Liu X, Wu J, Lou C, Zhang Q, Chen H, Yang Z, Long S, Wang Y, Shang Z, Hu Z, Zhang R, Zhang J, Zeng Z. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression. Biochim Biophys Acta Mol Basis Dis 2022;1868:166521. [PMID: 35985448 DOI: 10.1016/j.bbadis.2022.166521] [Reference Citation Analysis]
3 Méndez-lópez LF. Revisiting Epithelial Carcinogenesis. IJMS 2022;23:7437. [DOI: 10.3390/ijms23137437] [Reference Citation Analysis]
4 Mortezaee K, Majidpoor J. CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives. Front Immunol 2022;13:864298. [DOI: 10.3389/fimmu.2022.864298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Song C, Chen J, Zhang C, Dong D. An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma. Front Oncol 2022;12:849717. [PMID: 35280819 DOI: 10.3389/fonc.2022.849717] [Reference Citation Analysis]
6 Darvishi B, Eisavand MR, Majidzadeh-a K, Farahmand L. Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance. Br J Cancer. [DOI: 10.1038/s41416-021-01680-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jacquemin V, Antoine M, Dom G, Detours V, Maenhaut C, Dumont JE. Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications. Cancers (Basel) 2022;14:280. [PMID: 35053446 DOI: 10.3390/cancers14020280] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen Z, Zhuo S, He G, Tang J, Hao W, Gao WQ, Yang K, Xu H. Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas. Front Cell Dev Biol 2021;9:721897. [PMID: 34778248 DOI: 10.3389/fcell.2021.721897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Mortezaee K, Majidpoor J. Key promoters of tumor hallmarks. Int J Clin Oncol 2021. [PMID: 34773527 DOI: 10.1007/s10147-021-02074-9] [Reference Citation Analysis]
10 De P, Aske J, Dey N. Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy. Cancers (Basel) 2021;13:5246. [PMID: 34680395 DOI: 10.3390/cancers13205246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 2021;20:131. [PMID: 34635121 DOI: 10.1186/s12943-021-01428-1] [Cited by in F6Publishing: 79] [Reference Citation Analysis]
12 Najafi M, Majidpoor J, Toolee H, Mortezaee K. The current knowledge concerning solid cancer and therapy. J Biochem Mol Toxicol 2021;:e22900. [PMID: 34462987 DOI: 10.1002/jbt.22900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
13 Makaremi S, Asadzadeh Z, Hemmat N, Baghbanzadeh A, Sgambato A, Ghorbaninezhad F, Safarpour H, Argentiero A, Brunetti O, Bernardini R, Silvestris N, Baradaran B. Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects. Biomedicines 2021;9:1075. [PMID: 34572263 DOI: 10.3390/biomedicines9091075] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
14 Mortezaee K. Normalization in tumor ecosystem: Opportunities and challenges. Cell Biol Int 2021. [PMID: 34189798 DOI: 10.1002/cbin.11655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chen L, Musa AE. Boosting immune system against cancer by resveratrol. Phytother Res 2021. [PMID: 34101276 DOI: 10.1002/ptr.7189] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
16 Mortezaee K. Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives. Life Sci 2021;277:119627. [PMID: 34004256 DOI: 10.1016/j.lfs.2021.119627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
17 Majidpoor J, Mortezaee K. The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives. Clinical Immunology 2021;226:108707. [DOI: 10.1016/j.clim.2021.108707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
18 Mortezaee K. Organ tropism in solid tumor metastasis: an updated review. Future Oncology 2021;17:1943-61. [DOI: 10.2217/fon-2020-1103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
19 Majidpoor J, Mortezaee K. Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr) 2021;44:715-37. [PMID: 33835425 DOI: 10.1007/s13402-021-00602-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
20 Ping Q, Yan R, Cheng X, Wang W, Zhong Y, Hou Z, Shi Y, Wang C, Li R. Cancer-associated fibroblasts: overview, progress, challenges, and directions. Cancer Gene Ther 2021. [PMID: 33712707 DOI: 10.1038/s41417-021-00318-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
21 Mortezaee K. Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer. J Biochem Mol Toxicol 2021;35:e22708. [PMID: 33491255 DOI: 10.1002/jbt.22708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
22 Piscatelli JA, Ban J, Lucas AT, Zamboni WC. Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems. Pharmaceutics 2021;13:114. [PMID: 33477395 DOI: 10.3390/pharmaceutics13010114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Majidpoor J, Mortezaee K. Steps in metastasis: an updated review. Med Oncol 2021;38:3. [PMID: 33394200 DOI: 10.1007/s12032-020-01447-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
24 Mortezaee K. Redox tolerance and metabolic reprogramming in solid tumors. Cell Biol Int 2021;45:273-86. [PMID: 33236822 DOI: 10.1002/cbin.11506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
25 Mortezaee K, Najafi M. Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives. Crit Rev Oncol Hematol 2021;157:103180. [PMID: 33264717 DOI: 10.1016/j.critrevonc.2020.103180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
26 Qi L, Song F, Han Y, Zhang Y, Ding Y. Atractyloside targets cancer-associated fibroblasts and inhibits the metastasis of colon cancer. Ann Transl Med 2020;8:1443. [PMID: 33313188 DOI: 10.21037/atm-20-1531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Freeman P, Mielgo A. Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities. Cancers (Basel) 2020;12:E2687. [PMID: 32967079 DOI: 10.3390/cancers12092687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
28 Okwor CIA, Oh JS, Crawley AM, Cooper CL, Lee SH. Expression of Inhibitory Receptors on T and NK Cells Defines Immunological Phenotypes of HCV Patients with Advanced Liver Fibrosis. iScience 2020;23:101513. [PMID: 32920488 DOI: 10.1016/j.isci.2020.101513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mortezaee K. Immune escape: A critical hallmark in solid tumors. Life Sci 2020;258:118110. [PMID: 32698074 DOI: 10.1016/j.lfs.2020.118110] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
30 Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives. Int Immunopharmacol 2020;87:106807. [PMID: 32683299 DOI: 10.1016/j.intimp.2020.106807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
31 Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. Damage-associated molecular patterns in tumor radiotherapy. Int Immunopharmacol 2020;86:106761. [PMID: 32629409 DOI: 10.1016/j.intimp.2020.106761] [Cited by in Crossref: 9] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
32 Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, Li CY, Su YR, Liu YR, Sang X, Wan Q, Liu C, Yang L, Wang ZC. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Prolif 2020;53:e12865. [PMID: 32588948 DOI: 10.1111/cpr.12865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
33 Mortezaee K, Shabeeb D, Musa AE, Najafi M, Farhood B. Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization. Curr Clin Pharmacol 2019;14:41-53. [PMID: 30360725 DOI: 10.2174/1574884713666181025141559] [Cited by in Crossref: 23] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
34 Mortezaee K. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis. Life Sci 2020;249:117534. [PMID: 32156548 DOI: 10.1016/j.lfs.2020.117534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 61] [Article Influence: 19.5] [Reference Citation Analysis]
35 Mortezaee K. Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2α. Life Sciences 2020;242:117145. [DOI: 10.1016/j.lfs.2019.117145] [Cited by in Crossref: 19] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
36 Andreicuț AD, Fischer-Fodor E, Pârvu AE, Ţigu AB, Cenariu M, Pârvu M, Cătoi FA, Irimie A. Antitumoral and Immunomodulatory Effect of Mahonia aquifolium Extracts. Oxid Med Cell Longev 2019;2019:6439021. [PMID: 31949880 DOI: 10.1155/2019/6439021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Jiang Y, Zhan H. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion. Cancer Lett 2020;468:72-81. [PMID: 31605776 DOI: 10.1016/j.canlet.2019.10.013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 19.7] [Reference Citation Analysis]
38 Kourko O, Seaver K, Odoardi N, Basta S, Gee K. IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer. Front Oncol 2019;9:969. [PMID: 31681561 DOI: 10.3389/fonc.2019.00969] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
39 Xin X, Yang S. A Dual Fluorescent 3-D Multicellular Coculture of Breast Cancer MCF-7 and Fibroblast NIH-3T3 Cells for High Throughput Cancer Drug Screening. Biochemical Engineering Journal 2019;148:152-61. [DOI: 10.1016/j.bej.2019.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Saleh R, Elkord E. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression. Semin Cancer Biol 2020;65:13-27. [PMID: 31362073 DOI: 10.1016/j.semcancer.2019.07.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 17.3] [Reference Citation Analysis]
41 Vivacqua A, Muoio MG, Miglietta AM, Maggiolini M. Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors. Cancers (Basel) 2019;11:E412. [PMID: 30909585 DOI: 10.3390/cancers11030412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
42 Mortezaee K, Salehi E, Mirtavoos-Mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy. J Cell Physiol 2019;234:12537-50. [PMID: 30623450 DOI: 10.1002/jcp.28122] [Cited by in Crossref: 65] [Cited by in F6Publishing: 114] [Article Influence: 21.7] [Reference Citation Analysis]
43 Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019;234:12173-87. [PMID: 30537043 DOI: 10.1002/jcp.27955] [Cited by in Crossref: 56] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
44 Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol 2019;234:8381-95. [DOI: 10.1002/jcp.27740] [Cited by in Crossref: 117] [Cited by in F6Publishing: 183] [Article Influence: 29.3] [Reference Citation Analysis]
45 Vivacqua A, Sebastiani A, Miglietta AM, Rigiracciolo DC, Cirillo F, Galli GR, Talia M, Santolla MF, Lappano R, Giordano F, Panno ML, Maggiolini M. miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs). Cells 2018;7:E203. [PMID: 30423928 DOI: 10.3390/cells7110203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]